Evaluation of clearance studies in lupus nephritis.
D000293:Adolescent; D000328:Adult; D000618:Aminohippuric Acids; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001799:Blood Sedimentation; D003404:Creatinine / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000652:urine*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007444:Inulin; D007668:Kidney / Q000503:physiopathology*; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000652:urine*; D008297:Male; D008657:Metabolic Clearance Rate; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies
D000618:Aminohippuric Acids; D007444:Inulin; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone